Clinical impact of novel cardiovascular magnetic resonance technology on patients with congenital heart disease: a scientific statement of the Association for European Pediatric and Congenital Cardiology and the European Association of Cardiovascular Imaging of the European Society of Cardiology.

Voges I, Raimondi F, McMahon CJ, Ait-Ali L, Babu-Narayan SV, Botnar RM, Burkhardt B, Gabbert DD, Grosse-Wortmann L, Hasan H, Hansmann G, Helbing WA, Krupickova S, Latus H, Martini N, Martins D, Muthurangu V, Ojala T, Van Ooij P, Pushparajah K, Rodriguez-Palomares J, Sarikouch S, Grotenhuis HB, Greil FG, Bohbot Y, Cikes M, Dweck M, Donal E, Grapsa J, Keenan N, Petrescu AM, Szabo L, Ricci F, Uusitalo V (2024)

Publication Type: Journal article, Review article

Publication year: 2024

Journal

Book Volume: 25

Pages Range: e274-e294

Journal Issue: 12

DOI: 10.1093/ehjci/jeae172

Abstract

Cardiovascular magnetic resonance (CMR) imaging is recommended in patients with congenital heart disease (CHD) in clinical practice guidelines as the imaging standard for a large variety of diseases. As CMR is evolving, novel techniques are becoming available. Some of them are already used clinically, whereas others still need further evaluation. In this statement, the authors give an overview of relevant new CMR techniques for the assessment of CHD. Studies with reference values for these new techniques are listed in the Supplementary data online, supplement.

Involved external institutions

Royal Brompton Hospital United Kingdom (GB) Klinikum Stuttgart Germany (DE) Fondazione Toscana Gabriele Monasterio Italy (IT) Hospital de Santa Cruz (HSC) / Centro Hospitalar de Lisboa Ocidental Portugal (PT) University College London (UCL) United Kingdom (GB) Helsinki University Central Hospital (HUCH) / Helsingin seudun yliopistollinen keskussairaala (HYKS) Finland (FI) Amsterdam University Medical Centers (Amsterdam UMC) / Amsterdam Universitair Medische Centra Netherlands (NL) King’s College London United Kingdom (GB) Instituto de Salud Carlos III (Institute of Health Carlos III, ISCIII) Spain (ES) Medizinische Hochschule Hannover (MHH) / Hannover Medical School Germany (DE) Wilhelmina Kinderziekenhuis Netherlands (NL) University of Texas Southwestern Medical Center (UT Southwestern) United States (USA) (US) Universitätsklinikum Schleswig-Holstein (UKSH) Germany (DE) Azienda Ospedaliera Papa Giovanni XXIII Italy (IT) Temple Street Children's University Hospital / Children's Health Ireland (CHI) Ireland (IE) Istituto di Fisiologia Clinica (IFC) Italy (IT) Universitäts-Kinderspital Zürich Switzerland (CH) Oregon Health and Science University (OSHU) United States (USA) (US) Erasmus MC - Sophia Children’s Hospital Netherlands (NL)

How to cite

APA:

Voges, I., Raimondi, F., McMahon, C.J., Ait-Ali, L., Babu-Narayan, S.V., Botnar, R.M.,... Uusitalo, V. (2024). Clinical impact of novel cardiovascular magnetic resonance technology on patients with congenital heart disease: a scientific statement of the Association for European Pediatric and Congenital Cardiology and the European Association of Cardiovascular Imaging of the European Society of Cardiology. European Heart Journal - Cardiovascular Imaging, 25(12), e274-e294. https://doi.org/10.1093/ehjci/jeae172

MLA:

Voges, Inga, et al. "Clinical impact of novel cardiovascular magnetic resonance technology on patients with congenital heart disease: a scientific statement of the Association for European Pediatric and Congenital Cardiology and the European Association of Cardiovascular Imaging of the European Society of Cardiology." European Heart Journal - Cardiovascular Imaging 25.12 (2024): e274-e294.

BibTeX: Download